Skip to content

The Future of Clinical Trials in Infectious Diseases

European Clinical Research Alliance on Infectious Diseases

Partner with Ecraid to Accelerate Infectious Diseases and Antimicrobial Resistance Research

1,200 hospital sites 250 primary care sites in 42 countries
'' ''

About Ecraid

Ecraid advances clinical research in the field of infectious diseases by coordinating Europe's largest academia-driven, self-sustainable 'warm-base' network.

As an academic, not-for-profit foundation, we prioritise scientific rigor and high-quality research. 

Ecraid's mission is centred on improving clinical evidence for infectious diseases and antimicrobial resistance. 

We are building sustainable research capacity with a single point of access to leading academic experts, key opinion leaders and engaged networks.

Microscope

Conduct More Impactful Research

Tap into Ecraid's established network and expertise in infectious diseases to deliver high-quality studies with uncompromising scientific integrity.

Clinical studies

Generate Evidence Faster and Smarter

Leverage our innovative trial designs and powerful data insights to run efficient, flexible studies - while reducing your investment requirements.

Patients selected for trials

Accelerate Treatments to Patients

Access our ready-to-go clinical research network and epidemiological data to select sites smarter, minimise delays, and bring breakthrough therapies to patients sooner.

Shaping the Future of Clinical Research through Innovative Trial Designs and Engaged Networks

Whitepaper Adaptive Platform Trial Design
ACCESS OUR WHITE PAPER

Step into the Future of ID Clinical Research alongside Ecraid

Traditional clinical trials are often too slow to respond to fast-moving infectious threats. Ecraid is changing that. Through new trial designs like Adaptive Platform Trials (APTs) and integrated European networks, we are paving the way for innovations in infectious disease research.

APTs are a powerful, flexible alternative. They allow for continuous enrolment, simultaneous testing of multiple interventions, and real-time adjustments based on emerging data, leading to faster and more efficient research conclusions. 

Would you like to know more?

Whitepaper warm-base networks
ACCESS OUR WHITE PAPER

Benefit from Ecraid's Large Expertise Infrastructure for Efficient and High-quality ID research

Efficiency and quality in trials should never be a trade-off. Ecraid is the premier European academic network for infectious diseases and AMR, comprising over 1,200 clinical sites across 42 countries.

This warm-base network is supported by a coordinating team that uses its deep knowledge of the sites’ capabilities and experience to match each study with the sites that best fit its needs. These capabilities, combined with access to epidemiological data on AMR and HAIs across Europe, ensure smart site selection, less delays, increased efficiency and high-quality clinical trials.

Ecraid Offers You a Comprehensive Array of Services and Solutions for High-quality Clinical Trials

Accelerate Your Infectious Disease Trials